As part of this strategic alignment, John J. Viscogliosi will join the Plethy board, bringing his deep expertise in scaling healthcare companies and driving innovation in the MSK space. His ...

Q2 2025 Earnings Call Transcript January 8, 2025 AngioDynamics, Inc. beats earnings expectations. Reported EPS is $-0.04, ...

Vensana Capital today announced the closing of Vensana Capital III with $425 million in committed capital. The fund was oversubscribed at its hard cap with the support of the firm’s existing limited ...

Global healthcare private equity (PE) soared in 2024 to an estimated $115 billion, reaching the second-highest deal value total on record. This surge was propelled by an increase in ...

Despite the pause, the company clarified that the suspension does not impact commercial activity outside the US.

Leuven, Belgium-based Capricorn Partners, announced the first close of its Capricorn Health-tech Fund II at €51M.

Oxford Cancer Analytics (OXcan), the medtech company developing blood tests for early cancer detection using advanced proteomics and AI, today announced it has raised US$11 million in Series A funding ...

This latest investment, which brings OXcan’s total funding to date to $16.7 million, will be used to develop and globally ...

Investors may have flocked to health care AI companies in recent years, but funding has leveled off and backers are "becoming ...

ALAFIA AI's supercomputer accelerates AI workflows in healthcare, reducing task times from 30-60 minutes to under 30 seconds.

Bernstein raised the firm’s price target on Insulet (PODD) to $315 from $305 and keeps an Outperform rating on the shares as part of a broader ...

Bernstein raised the firm’s price target on Boston Scientific (BSX) to $110 from $100 and keeps an Outperform rating on the shares as part of a ...